Ruizhan Tong

1.3k citations
20 papers · 450 indexed · h-index 11
Topics
CAR-T cell therapy research (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)Lung Cancer Research Studies (4 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Ruizhan Tong

20 papers receiving 442 citations

Peers

Ruizhan Tong
Comparison fields: 5 of 78
  • Molecular Biology 211
  • Oncology 203
  • Immunology 91
  • Cancer Research 75
  • Pulmonary and Respiratory Medicine 68
Replace Liting You with:
Liting You China
Elliot H. Akama‐Garren United States
Yun Xu China
Madeline A. Hwee United States
Jaehun Lee South Korea
Dale W. Garsed Australia
Susmita G. Ramanand United States
Yingxiao Chen China
Hyo‐Gyoung Kang South Korea
Carolynn E. Ohlson United States
Ruizhan Tong relative to Liting You China Liting You's profile →
Citations per field
00.5×2.7×
Liting You · 1×
Citations per year

Countries citing papers authored by Ruizhan Tong

Since Specialization
Citations

This map shows the geographic impact of Ruizhan Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizhan Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizhan Tong more than expected).

Fields of papers citing papers by Ruizhan Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizhan Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizhan Tong. The network helps show where Ruizhan Tong may publish in the future.

Co-authorship network of co-authors of Ruizhan Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizhan Tong. A scholar is included among the top collaborators of Ruizhan Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizhan Tong. Ruizhan Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 7
4 63
5 8
6 9
7 28
8 3
9 117
10 80
11 11
12 11
13 13
14 26
15 10
16 28
17 6
18 18
19 2
20 6

About Ruizhan Tong

Ruizhan Tong is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 450 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (203 citations), Business and International Management (11 citations) and Cancer Research (75 citations). Ruizhan Tong has collaborated with scholars based in China, United States and Canada. Frequent co-authors include You Lü, Jianxin Xue, Mengqian Li, Yuncong Liu, Liting You, Limei Yin, Li Wu, Zhuoran Yao, Limei Yin and Yue Zheng. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026